Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/16/12 | 8-K | Current report filing |
|
4 | |
| 10/16/12 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act |
|
6 | |
| 10/12/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/12/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/11/12 | 8-K | Current report filing |
|
5 | |
| 10/11/12 | 3/A | F-1MEF |
|
2 | |
| 10/11/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/09/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
31 | |
| 10/01/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/28/12 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
25 |
